Lcn2 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] | CTD | PMID:31150632 |
Lcn2 | Rat | (-)-citrinin | increases expression | EXP | | 6480464 | Citrinin results in increased expression of LCN2 mRNA | CTD | PMID:23856526 |
Lcn2 | Rat | 1,1-dichloroethene | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of LCN2 mRNA | CTD | PMID:26682919 |
Lcn2 | Rat | 1-aminobenzotriazole | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein | CTD | PMID:36227364 |
Lcn2 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA | CTD | PMID:18289764 more ... |
Lcn2 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA] and PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA]] | CTD | PMID:27853831 |
Lcn2 | Rat | 1-naphthyl isothiocyanate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA | CTD | PMID:27853831 |
Lcn2 | Rat | 11-deoxycorticosterone | multiple interactions | EXP | | 6480464 | [Desoxycorticosterone co-treated with Sodium Chloride more ... | CTD | PMID:21135038 |
Lcn2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LCN2 mRNA and Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of LCN2 mRNA] | CTD | PMID:12072388 and PMID:17942748 |
Lcn2 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of LCN2 mRNA | CTD | PMID:16467188 and PMID:17942748 |
Lcn2 | Rat | 17beta-estradiol | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased expression of LCN2 mRNA more ... | CTD | PMID:15866426 more ... |
Lcn2 | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of LCN2 mRNA | CTD | PMID:15456929 and PMID:26945725 |
Lcn2 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA and [Estradiol co-treated with Plant Preparations] results in increased expression of LCN2 mRNA | CTD | PMID:26945725 and PMID:32741896 |
Lcn2 | Rat | 17beta-estradiol | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Estradiol results in increased expression of LCN2 mRNA | CTD | PMID:15289156 more ... |
Lcn2 | Rat | 17beta-estradiol | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of LCN2 mRNA | CTD | PMID:19619570 |
Lcn2 | Rat | 17beta-estradiol | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Estradiol affects the expression of LCN2 mRNA | CTD | PMID:15598610 |
Lcn2 | Rat | 17beta-estradiol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of LCN2 mRNA] and Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LCN2 mRNA] | CTD | PMID:16977382 and PMID:24052564 |
Lcn2 | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA | CTD | PMID:32741896 |
Lcn2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 |
Lcn2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LCN2 mRNA more ... | CTD | PMID:15667827 more ... |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LCN2 mRNA | CTD | PMID:28922406 |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCN2 mRNA | CTD | PMID:20959002 more ... |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCN2 mRNA | CTD | PMID:17949056 and PMID:28213091 |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LCN2 mRNA | CTD | PMID:16611356 |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LCN2 mRNA | CTD | PMID:19619570 |
Lcn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCN2 mRNA | CTD | PMID:19619570 |
Lcn2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:25768209 |
Lcn2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | AHR protein promotes the reaction [2 more ... | CTD | PMID:25768209 |
Lcn2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA] | CTD | PMID:18200517 |
Lcn2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA | CTD | PMID:17982090 and PMID:18200517 |
Lcn2 | Rat | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of LCN2 mRNA | CTD | PMID:21346803 |
Lcn2 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
Lcn2 | Rat | 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of LCN2 mRNA | CTD | PMID:17178593 |
Lcn2 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of LCN2 mRNA | CTD | PMID:30851411 |
Lcn2 | Rat | 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases secretion | EXP | | 6480464 | Puromycin Aminonucleoside results in increased secretion of LCN2 protein | CTD | PMID:20438795 |
Lcn2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:20959002 |
Lcn2 | Rat | 3,4-dichloroaniline | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | 3 and 4-dichloroaniline results in increased expression of LCN2 mRNA | CTD | PMID:24172598 |
Lcn2 | Rat | 3,4-dichloroaniline | increases expression | EXP | | 6480464 | 3 and 4-dichloroaniline results in increased expression of LCN2 mRNA | CTD | PMID:24172598 |
Lcn2 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of LCN2 mRNA | CTD | PMID:20409345 |
Lcn2 | Rat | 3-chloropropane-1,2-diol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of LCN2 mRNA | CTD | PMID:33187795 |
Lcn2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LCN2 mRNA | CTD | PMID:16054899 |
Lcn2 | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of LCN2 mRNA | CTD | PMID:25380136 |
Lcn2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of LCN2 mRNA | CTD | PMID:39298647 |
Lcn2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of LCN2 mRNA | CTD | PMID:33297965 |
Lcn2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of LCN2 mRNA | CTD | PMID:28973697 |
Lcn2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Fenretinide results in increased expression of LCN2 mRNA and Fenretinide results in increased expression of LCN2 protein | CTD | PMID:16671099 |
Lcn2 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of LCN2 mRNA | CTD | PMID:22504374 |
Lcn2 | Rat | 8-anilinonaphthalene-1-sulfonic acid | affects binding | ISO | LCN2 (Homo sapiens) | 6480464 | 1-anilino-8-naphthalenesulfonate binds to LCN2 protein | CTD | PMID:16461020 |
Lcn2 | Rat | 9-cis-retinoic acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Alitretinoin results in increased expression of LCN2 mRNA | CTD | PMID:15982314 |
Lcn2 | Rat | acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Azoxymethane results in decreased expression of LCN2 mRNA] | CTD | PMID:20043115 |
Lcn2 | Rat | Actein | increases expression | EXP | | 6480464 | actein results in increased expression of LCN2 protein | CTD | PMID:29969672 |
Lcn2 | Rat | adefovir | increases secretion | EXP | | 6480464 | adefovir results in increased secretion of LCN2 protein | CTD | PMID:27742868 |
Lcn2 | Rat | adefovir pivoxil | increases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | adefovir dipivoxil results in increased secretion of LCN2 protein | CTD | PMID:24714768 |
Lcn2 | Rat | aflatoxin B1 | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of LCN2 mRNA | CTD | PMID:19770486 |
Lcn2 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of LCN2 mRNA | CTD | PMID:33354967 |
Lcn2 | Rat | aflatoxin B1 | increases methylation | ISO | LCN2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LCN2 intron | CTD | PMID:30157460 |
Lcn2 | Rat | Aflatoxin B2 alpha | decreases methylation | ISO | LCN2 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of LCN2 intron | CTD | PMID:30157460 |
Lcn2 | Rat | agomelatine | multiple interactions | EXP | | 6480464 | agomelatine inhibits the reaction [Dietary Fats results in increased expression of LCN2 protein] | CTD | PMID:34081941 |
Lcn2 | Rat | aldehydo-D-glucosamine | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of LCN2 mRNA | CTD | PMID:17178593 |
Lcn2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LCN2 mRNA | CTD | PMID:37567420 |
Lcn2 | Rat | all-trans-4-oxoretinoic acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | 4-oxoretinoic acid results in increased expression of LCN2 mRNA | CTD | PMID:15982314 |
Lcn2 | Rat | all-trans-retinoic acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Tretinoin metabolite results in increased expression of LCN2 mRNA more ... | CTD | PMID:15982314 more ... |
Lcn2 | Rat | all-trans-retinoic acid | increases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | Tretinoin results in increased secretion of LCN2 protein | CTD | PMID:16671099 |
Lcn2 | Rat | allopurinol | increases expression | EXP | | 6480464 | Allopurinol results in increased expression of LCN2 mRNA | CTD | PMID:37876353 |
Lcn2 | Rat | aluminium oxide | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Nanotubes and Carbon co-treated with Aluminum Oxide] results in increased secretion of LCN2 protein | CTD | PMID:25598225 |
Lcn2 | Rat | amlodipine | multiple interactions | EXP | | 6480464 | Amlodipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein] | CTD | PMID:36207783 |
Lcn2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of LCN2 mRNA | CTD | PMID:16483693 |
Lcn2 | Rat | amphotericin B | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Amphotericin B analog results in decreased expression of LCN2 mRNA | CTD | PMID:28534445 |
Lcn2 | Rat | amphotericin B methyl ester | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | methylamphotericin B results in increased expression of LCN2 mRNA | CTD | PMID:22863853 |
Lcn2 | Rat | anethole | multiple interactions | EXP | | 6480464 | anethole inhibits the reaction [Doxorubicin results in increased expression of LCN2 protein] | CTD | PMID:39029857 |
Lcn2 | Rat | anthocyanin | multiple interactions | EXP | | 6480464 | Anthocyanins inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 protein] | CTD | PMID:30825423 |
Lcn2 | Rat | aristolochic acid A | multiple interactions | EXP | | 6480464 | [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of LCN2 protein | CTD | PMID:23912714 |
Lcn2 | Rat | arsenous acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of LCN2 mRNA | CTD | PMID:19763917 |
Lcn2 | Rat | atorvastatin calcium | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of LCN2 mRNA | CTD | PMID:29679711 |
Lcn2 | Rat | atorvastatin calcium | multiple interactions | EXP | | 6480464 | [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] and Atorvastatin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] | CTD | PMID:32259528 |
Lcn2 | Rat | Azoxymethane | decreases expression | EXP | | 6480464 | Azoxymethane results in decreased expression of LCN2 mRNA | CTD | PMID:20043115 |
Lcn2 | Rat | Azoxymethane | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Azoxymethane results in decreased expression of LCN2 mRNA] | CTD | PMID:20043115 |
Lcn2 | Rat | bacitracin | increases expression | EXP | | 6480464 | Bacitracin results in increased expression of LCN2 mRNA | CTD | PMID:18289764 |
Lcn2 | Rat | benzo[a]pyrene | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of LCN2 mRNA | CTD | PMID:19770486 |
Lcn2 | Rat | benzo[a]pyrene | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [corannulene co-treated with Benzo(a)pyrene] results in decreased expression of LCN2 mRNA | CTD | PMID:32417428 |
Lcn2 | Rat | benzo[a]pyrene | decreases methylation | ISO | LCN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of LCN2 exon | CTD | PMID:27901495 |
Lcn2 | Rat | benzo[a]pyrene | affects methylation | ISO | LCN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LCN2 promoter | CTD | PMID:27901495 |
Lcn2 | Rat | benzo[a]pyrene | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LCN2 mRNA | CTD | PMID:22228805 and PMID:22610609 |
Lcn2 | Rat | benzo[a]pyrene | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Benzo(a)pyrene affects the expression of LCN2 mRNA | CTD | PMID:22342234 |
Lcn2 | Rat | benzo[a]pyrene | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of LCN2 mRNA | CTD | PMID:22316170 |
Lcn2 | Rat | Benzo[ghi]perylene | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in increased expression of LCN2 mRNA | CTD | PMID:26377693 |
Lcn2 | Rat | beta-D-glucosamine | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of LCN2 mRNA | CTD | PMID:17178593 |
Lcn2 | Rat | beta-lapachone | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of LCN2 mRNA | CTD | PMID:38218311 |
Lcn2 | Rat | bicalutamide | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | bicalutamide results in increased expression of LCN2 mRNA | CTD | PMID:15638997 |
Lcn2 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of LCN2 mRNA | CTD | PMID:19850644 |
Lcn2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of LCN2 mRNA | CTD | PMID:34319233 |
Lcn2 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA | CTD | PMID:31199487 |
Lcn2 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein more ... | CTD | PMID:19850644 more ... |
Lcn2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LCN2 mRNA | CTD | PMID:15456929 |
Lcn2 | Rat | bisphenol A | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of LCN2 mRNA | CTD | PMID:36232920 |
Lcn2 | Rat | bisphenol A | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LCN2 mRNA | CTD | PMID:32156529 and PMID:34281243 |
Lcn2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LCN2 mRNA | CTD | PMID:32145629 and PMID:34947998 |
Lcn2 | Rat | bisphenol A | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of LCN2 mRNA | CTD | PMID:29718440 |
Lcn2 | Rat | bisphenol A | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of LCN2 mRNA and bisphenol A results in decreased expression of LCN2 protein | CTD | PMID:27312807 more ... |
Lcn2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of LCN2 mRNA | CTD | PMID:25181051 |
Lcn2 | Rat | bisphenol A | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] | CTD | PMID:27082013 |
Lcn2 | Rat | bisphenol A | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | bisphenol A affects the expression of LCN2 mRNA | CTD | PMID:27082013 |
Lcn2 | Rat | bleomycin A2 | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Bleomycin results in increased expression of LCN2 mRNA and Bleomycin results in increased expression of LCN2 protein | CTD | PMID:26345256 |
Lcn2 | Rat | Botulinum toxin type A | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Botulinum Toxins and Type A results in increased expression of LCN2 mRNA | CTD | PMID:33529366 |
Lcn2 | Rat | butanal | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of LCN2 mRNA | CTD | PMID:26079696 |
Lcn2 | Rat | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA | CTD | PMID:31199487 |
Lcn2 | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein | CTD | PMID:38954831 |
Lcn2 | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of LCN2 mRNA | CTD | PMID:20471445 |
Lcn2 | Rat | cadmium atom | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LCN2 mRNA | CTD | PMID:29741670 |
Lcn2 | Rat | cadmium atom | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Cadmium results in increased expression of LCN2 protein | CTD | PMID:33603096 |
Lcn2 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | Deferoxamine inhibits the reaction [Cadmium results in increased expression of LCN2 protein] more ... | CTD | PMID:37342552 more ... |
Lcn2 | Rat | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of LCN2 protein | CTD | PMID:37342552 more ... |
Lcn2 | Rat | cadmium dichloride | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of LCN2 mRNA | CTD | PMID:21457566 and PMID:38382870 |
Lcn2 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Cadmium Chloride results in increased export of LCN2 protein] | CTD | PMID:29421648 |
Lcn2 | Rat | cadmium dichloride | increases export | EXP | | 6480464 | Cadmium Chloride results in increased export of LCN2 protein | CTD | PMID:29421648 |
Lcn2 | Rat | cadmium dichloride | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LCN2 mRNA | CTD | PMID:29741670 |
Lcn2 | Rat | cadmium dichloride | decreases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased secretion of LCN2 protein | CTD | PMID:27888128 |
Lcn2 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of LCN2 mRNA | CTD | PMID:25993096 |
Lcn2 | Rat | cadmium dichloride | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of LCN2 mRNA | CTD | PMID:24982889 |
Lcn2 | Rat | cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of LCN2 mRNA | CTD | PMID:22110744 |
Lcn2 | Rat | calcitriol | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of LCN2 mRNA | CTD | PMID:26485663 |
Lcn2 | Rat | cannabidiol | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Cannabidiol results in increased expression of LCN2 mRNA | CTD | PMID:21542829 |
Lcn2 | Rat | cannabidiol | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of LCN2 mRNA | CTD | PMID:33244087 |
Lcn2 | Rat | carbon nanotube | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Nanotubes and Carbon co-treated with Aluminum Oxide] results in increased secretion of LCN2 protein | CTD | PMID:25598225 |
Lcn2 | Rat | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of LCN2 mRNA | CTD | PMID:19836432 and PMID:24911292 |
Lcn2 | Rat | carbon nanotube | increases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased secretion of LCN2 protein | CTD | PMID:25598225 |
Lcn2 | Rat | carbon nanotube | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 more ... |
Lcn2 | Rat | carmustine | increases response to substance | ISO | LCN2 (Homo sapiens) | 6480464 | LCN2 protein results in increased susceptibility to Carmustine | CTD | PMID:19860839 |
Lcn2 | Rat | carmustine | increases response to substance | EXP | | 6480464 | LCN2 protein results in increased susceptibility to Carmustine | CTD | PMID:19860839 |
Lcn2 | Rat | carmustine | multiple interactions | EXP | | 6480464 | [LCN2 protein co-treated with Carmustine] results in increased cleavage of and results in increased activity of CASP3 protein and LCN2 protein promotes the reaction [Carmustine results in decreased phosphorylation of AKT1 protein] | CTD | PMID:19860839 |
Lcn2 | Rat | carnosic acid | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | salvin results in decreased expression of LCN2 protein | CTD | PMID:35926579 |
Lcn2 | Rat | chlordecone | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Chlordecone results in increased expression of LCN2 mRNA | CTD | PMID:33711761 |
Lcn2 | Rat | chloroquine | increases expression | EXP | | 6480464 | Chloroquine results in increased expression of LCN2 mRNA | CTD | PMID:19393257 |
Lcn2 | Rat | cholesterol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Cholesterol co-treated with 1 and 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of LCN2 mRNA | CTD | PMID:22129739 |
Lcn2 | Rat | choline | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Dietary Fats co-treated with Choline deficiency] results in increased expression of LCN2 mRNA more ... | CTD | PMID:29246445 and PMID:34416350 |
Lcn2 | Rat | cilnidipine | multiple interactions | EXP | | 6480464 | cilnidipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein] | CTD | PMID:36207783 |
Lcn2 | Rat | ciprofibrate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | ciprofibrate results in increased expression of LCN2 mRNA | CTD | PMID:12771043 |
Lcn2 | Rat | ciprofloxacin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of LCN2 mRNA | CTD | PMID:29679711 |
Lcn2 | Rat | cisplatin | increases secretion | EXP | | 6480464 | Cisplatin results in increased secretion of LCN2 protein | CTD | PMID:28885000 |
Lcn2 | Rat | cisplatin | multiple interactions | EXP | | 6480464 | [clemizole co-treated with Cisplatin] results in increased expression of LCN2 protein more ... | CTD | PMID:29216766 more ... |
Lcn2 | Rat | cisplatin | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of LCN2 mRNA and Cisplatin results in increased expression of LCN2 protein | CTD | PMID:27392435 and PMID:37863467 |
Lcn2 | Rat | cisplatin | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of LCN2 mRNA and Inositol inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] | CTD | PMID:27392435 and PMID:37863467 |
Lcn2 | Rat | cisplatin | decreases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | Cisplatin results in decreased secretion of LCN2 protein | CTD | PMID:27888128 |
Lcn2 | Rat | cisplatin | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Cisplatin results in increased expression of LCN2 mRNA and Cisplatin results in increased expression of LCN2 protein | CTD | PMID:24001450 more ... |
Lcn2 | Rat | cisplatin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | ferrostatin-1 inhibits the reaction [Cisplatin results in increased expression of LCN2 mRNA] more ... | CTD | PMID:24001450 more ... |
Lcn2 | Rat | cisplatin | increases response to substance | EXP | | 6480464 | LCN2 protein results in increased susceptibility to Cisplatin | CTD | PMID:19860839 |
Lcn2 | Rat | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of LCN2 mRNA and Cisplatin results in increased expression of LCN2 protein | CTD | PMID:15033597 more ... |
Lcn2 | Rat | clemizole | multiple interactions | EXP | | 6480464 | [clemizole co-treated with Cisplatin] results in increased expression of LCN2 protein and clemizole inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] | CTD | PMID:37102204 |
Lcn2 | Rat | cobalt dichloride | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of LCN2 mRNA | CTD | PMID:19376846 |
Lcn2 | Rat | copper atom | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of LCN2 mRNA | CTD | PMID:20971185 |
Lcn2 | Rat | copper atom | increases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Copper results in increased secretion of LCN2 protein | CTD | PMID:19635393 |
Lcn2 | Rat | copper(0) | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of LCN2 mRNA | CTD | PMID:20971185 |
Lcn2 | Rat | copper(0) | increases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Copper results in increased secretion of LCN2 protein | CTD | PMID:19635393 |
Lcn2 | Rat | copper(II) chloride | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of LCN2 mRNA | CTD | PMID:38568856 |
Lcn2 | Rat | cordycepin | affects expression | ISO | LCN2 (Homo sapiens) | 6480464 | cordycepin affects the expression of LCN2 mRNA | CTD | PMID:28099944 |
Lcn2 | Rat | corn oil | increases expression | EXP | | 6480464 | Corn Oil results in increased expression of LCN2 mRNA | CTD | PMID:22760963 |
Lcn2 | Rat | corosolic acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | corosolic acid results in increased expression of LCN2 mRNA | CTD | PMID:37939859 |
Lcn2 | Rat | crocidolite asbestos | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of LCN2 mRNA | CTD | PMID:23917077 |
Lcn2 | Rat | curcumin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA] | CTD | PMID:18200517 |
Lcn2 | Rat | curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Cadmium Chloride results in increased export of LCN2 protein] more ... | CTD | PMID:25119790 more ... |
Lcn2 | Rat | cyanuric acid | multiple interactions | EXP | | 6480464 | [cyanuric acid co-treated with melamine] results in increased expression of LCN2 mRNA and [melamine co-treated with cyanuric acid] results in increased expression of LCN2 mRNA | CTD | PMID:21784140 and PMID:23022069 |
Lcn2 | Rat | cyclophosphamide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Cyclophosphamide results in increased expression of LCN2 mRNA | CTD | PMID:15331540 and PMID:18433785 |
Lcn2 | Rat | cyclophosphamide | multiple interactions | EXP | | 6480464 | herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of LCN2 protein] | CTD | PMID:36198566 |
Lcn2 | Rat | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of LCN2 mRNA and Cyclophosphamide results in increased expression of LCN2 protein | CTD | PMID:20623750 and PMID:36198566 |
Lcn2 | Rat | cyclophosphamide | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of LCN2 mRNA | CTD | PMID:18433785 |
Lcn2 | Rat | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of LCN2 mRNA | CTD | PMID:21865292 |
Lcn2 | Rat | cyclosporin A | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of LCN2 mRNA] and TLR4 gene mutant form inhibits the reaction [Cyclosporine results in increased expression of LCN2 mRNA] | CTD | PMID:27585667 |
Lcn2 | Rat | cyclosporin A | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LCN2 mRNA | CTD | PMID:20106945 more ... |
Lcn2 | Rat | cyclosporin A | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of LCN2 mRNA | CTD | PMID:23958496 and PMID:27585667 |
Lcn2 | Rat | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of LCN2 mRNA | CTD | PMID:21865292 |
Lcn2 | Rat | D-glucose | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LCN2 mRNA | CTD | PMID:37567420 |
Lcn2 | Rat | dapagliflozin | multiple interactions | EXP | | 6480464 | [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] more ... | CTD | PMID:30551545 and PMID:32259528 |
Lcn2 | Rat | DDE | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of LCN2 mRNA | CTD | PMID:38568856 |
Lcn2 | Rat | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of LCN2 mRNA | CTD | PMID:23640034 |
Lcn2 | Rat | deferasirox | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | deferasirox results in increased expression of LCN2 protein | CTD | PMID:21439361 |
Lcn2 | Rat | deferasirox | increases expression | EXP | | 6480464 | deferasirox results in increased expression of LCN2 protein | CTD | PMID:21439361 |
Lcn2 | Rat | desferrioxamine B | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Deferoxamine affects the reaction [Magnetite Nanoparticles results in increased expression of LCN2 mRNA] and Deferoxamine inhibits the reaction [LCN2 protein results in decreased secretion of VEGFA protein] | CTD | PMID:17114340 and PMID:23086747 |
Lcn2 | Rat | desferrioxamine B | multiple interactions | EXP | | 6480464 | Deferoxamine inhibits the reaction [Cadmium results in increased expression of LCN2 protein] | CTD | PMID:39025289 |
Lcn2 | Rat | desferrioxamine B | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Deferoxamine results in increased expression of LCN2 mRNA | CTD | PMID:23086747 |
Lcn2 | Rat | dexamethasone | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LCN2 mRNA | CTD | PMID:16054899 |
Lcn2 | Rat | dexamethasone | decreases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Dexamethasone results in decreased secretion of LCN2 protein | CTD | PMID:28003376 |
Lcn2 | Rat | dexamethasone | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of LCN2 mRNA | CTD | PMID:23493372 and PMID:23946490 |
Lcn2 | Rat | dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Freund's Adjuvant results in increased expression of LCN2 mRNA] | CTD | PMID:21149847 |
Lcn2 | Rat | dextran sulfate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of LCN2 mRNA | CTD | PMID:23894361 |
Lcn2 | Rat | dextran sulfate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of LCN2 mRNA] | CTD | PMID:36519841 |
Lcn2 | Rat | Di-n-octyl phthalate | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Phthalic Acids results in increased abundance of di-n-octyl phthalate metabolite] which results in increased secretion of LCN2 protein | CTD | PMID:33052911 |
Lcn2 | Rat | diarsenic trioxide | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of LCN2 mRNA | CTD | PMID:19763917 |
Lcn2 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of LCN2 mRNA | CTD | PMID:21266533 |
Lcn2 | Rat | dibutyl phthalate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein | CTD | PMID:38954831 |
Lcn2 | Rat | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA | CTD | PMID:31199487 |
Lcn2 | Rat | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of LCN2 mRNA | CTD | PMID:23939143 |
Lcn2 | Rat | diclofenac | increases secretion | EXP | | 6480464 | Diclofenac results in increased secretion of LCN2 protein | CTD | PMID:38582345 |
Lcn2 | Rat | diclofenac | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Diclofenac results in increased expression of LCN2 mRNA | CTD | PMID:26934552 |
Lcn2 | Rat | diclofenac | multiple interactions | EXP | | 6480464 | diacerein inhibits the reaction [Diclofenac results in increased secretion of LCN2 protein] more ... | CTD | PMID:23939143 and PMID:38582345 |
Lcn2 | Rat | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of LCN2 mRNA | CTD | PMID:22546817 |
Lcn2 | Rat | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA | CTD | PMID:31199487 |
Lcn2 | Rat | diethyl phthalate | decreases expression | EXP | | 6480464 | diethyl phthalate results in decreased expression of LCN2 mRNA | CTD | PMID:32341500 |
Lcn2 | Rat | diethyl phthalate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein | CTD | PMID:38954831 |
Lcn2 | Rat | diethylstilbestrol | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of LCN2 mRNA | CTD | PMID:15289156 |
Lcn2 | Rat | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of LCN2 mRNA | CTD | PMID:21658437 |
Lcn2 | Rat | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA | CTD | PMID:31199487 |
Lcn2 | Rat | diisobutyl phthalate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein | CTD | PMID:38954831 |
Lcn2 | Rat | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA | CTD | PMID:31199487 |
Lcn2 | Rat | diisononyl phthalate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein | CTD | PMID:38954831 |
Lcn2 | Rat | dioxygen | increases expression | EXP | | 6480464 | Oxygen results in increased expression of LCN2 mRNA | CTD | PMID:22911455 |
Lcn2 | Rat | dioxygen | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [N-(oxo-5 more ... | CTD | PMID:19640911 and PMID:30529165 |
Lcn2 | Rat | diquat | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Diquat results in increased expression of LCN2 mRNA | CTD | PMID:36851058 |
Lcn2 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron metabolite results in increased expression of LCN2 mRNA | CTD | PMID:24172598 |
Lcn2 | Rat | doxorubicin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of LCN2 mRNA and Folic Acid inhibits the reaction [Doxorubicin results in increased expression of LCN2 mRNA] | CTD | PMID:21040762 and PMID:28608983 |
Lcn2 | Rat | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of LCN2 mRNA and Doxorubicin results in increased expression of LCN2 protein | CTD | PMID:35987278 and PMID:39029857 |
Lcn2 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | anethole inhibits the reaction [Doxorubicin results in increased expression of LCN2 protein] and tannic acid inhibits the reaction [Doxorubicin results in increased expression of LCN2 mRNA] | CTD | PMID:35987278 and PMID:39029857 |
Lcn2 | Rat | doxorubicin | increases secretion | EXP | | 6480464 | Doxorubicin results in increased secretion of LCN2 protein | CTD | PMID:28885000 |
Lcn2 | Rat | doxorubicin | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of LCN2 mRNA | CTD | PMID:15033991 more ... |
Lcn2 | Rat | doxycycline | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased expression of LCN2 mRNA] | CTD | PMID:18089841 |
Lcn2 | Rat | enilconazole | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | enilconazole results in increased expression of LCN2 | CTD | PMID:27393971 |
Lcn2 | Rat | epoxiconazole | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of LCN2 mRNA | CTD | PMID:35436446 |
Lcn2 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of LCN2 mRNA | CTD | PMID:16946407 |
Lcn2 | Rat | ethanol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of LCN2 mRNA | CTD | PMID:28285099 |
Lcn2 | Rat | etoposide | increases response to substance | EXP | | 6480464 | LCN2 protein results in increased susceptibility to Etoposide | CTD | PMID:19860839 |
Lcn2 | Rat | fentanyl | increases expression | EXP | | 6480464 | Fentanyl results in increased expression of LCN2 mRNA | CTD | PMID:36032789 |
Lcn2 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of LCN2 mRNA | CTD | PMID:31524104 |
Lcn2 | Rat | ferric ammonium citrate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | ferric ammonium citrate inhibits the reaction [bathophenanthroline disulfonic acid results in decreased expression of LCN2 protein] | CTD | PMID:17350462 |
Lcn2 | Rat | ferrostatin-1 | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | ferrostatin-1 inhibits the reaction [Cisplatin results in increased expression of LCN2 mRNA] | CTD | PMID:34785303 |
Lcn2 | Rat | ferrostatin-1 | multiple interactions | EXP | | 6480464 | ferrostatin-1 inhibits the reaction [Cadmium results in increased expression of LCN2 protein] | CTD | PMID:39025289 |
Lcn2 | Rat | fluconazole | increases expression | EXP | | 6480464 | Fluconazole results in increased expression of LCN2 mRNA | CTD | PMID:20623750 |
Lcn2 | Rat | folic acid | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of LCN2 mRNA and Folic Acid results in increased expression of LCN2 protein | CTD | PMID:23255615 and PMID:38272249 |
Lcn2 | Rat | folic acid | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | EGFR protein affects the reaction [Folic Acid results in increased expression of LCN2 protein] more ... | CTD | PMID:23255615 more ... |
Lcn2 | Rat | fomepizole | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Fomepizole inhibits the reaction [Acetaminophen results in increased expression of LCN2 protein] | CTD | PMID:38042273 |
Lcn2 | Rat | fragrance | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Perfume results in decreased expression of LCN2 mRNA | CTD | PMID:24768652 |
Lcn2 | Rat | fructose | multiple interactions | EXP | | 6480464 | [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] more ... | CTD | PMID:30551545 and PMID:32259528 |
Lcn2 | Rat | fructose | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LCN2 mRNA | CTD | PMID:37567420 |
Lcn2 | Rat | fumonisin B1 | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | fumonisin B1 results in increased expression of LCN2 mRNA | CTD | PMID:38705344 |
Lcn2 | Rat | fumonisin B1 | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of LCN2 mRNA] | CTD | PMID:38705344 |
Lcn2 | Rat | furan | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | furan results in increased expression of LCN2 mRNA | CTD | PMID:24183702 |
Lcn2 | Rat | gefitinib | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Gefitinib promotes the reaction [Folic Acid results in increased expression of LCN2 protein] | CTD | PMID:23255615 |
Lcn2 | Rat | gemfibrozil | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of LCN2 mRNA | CTD | PMID:30853469 |
Lcn2 | Rat | genistein | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Genistein results in increased expression of LCN2 mRNA | CTD | PMID:15289156 |
Lcn2 | Rat | gentamycin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Gentamicins results in increased expression of LCN2 mRNA] more ... | CTD | PMID:19349640 more ... |
Lcn2 | Rat | gentamycin | decreases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | Gentamicins results in decreased secretion of LCN2 protein | CTD | PMID:27888128 |
Lcn2 | Rat | gentamycin | increases secretion | EXP | | 6480464 | Gentamicins results in increased secretion of LCN2 protein | CTD | PMID:20816719 |
Lcn2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of LCN2 mRNA and Gentamicins results in increased expression of LCN2 protein | CTD | PMID:17636248 more ... |
Lcn2 | Rat | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of LCN2 mRNA | CTD | PMID:24136188 |
Lcn2 | Rat | glucose | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LCN2 mRNA | CTD | PMID:37567420 |
Lcn2 | Rat | glycidol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of LCN2 mRNA | CTD | PMID:33187795 |
Lcn2 | Rat | glycidyl methacrylate | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | glycidyl methacrylate results in decreased expression of LCN2 protein | CTD | PMID:36641056 |
Lcn2 | Rat | graphene oxide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | graphene oxide results in increased expression of LCN2 mRNA | CTD | PMID:33227293 |
Lcn2 | Rat | graphite | increases expression | EXP | | 6480464 | Graphite results in increased expression of LCN2 mRNA | CTD | PMID:29933104 |
Lcn2 | Rat | herbacetin | multiple interactions | EXP | | 6480464 | herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of LCN2 protein] | CTD | PMID:36198566 |
Lcn2 | Rat | Hexachloro-1,3-butadiene | decreases expression | EXP | | 6480464 | hexachlorobutadiene results in decreased expression of LCN2 mRNA | CTD | PMID:21905055 |
Lcn2 | Rat | Hexachloro-1,3-butadiene | increases expression | EXP | | 6480464 | hexachlorobutadiene results in increased expression of LCN2 protein | CTD | PMID:21259293 |
Lcn2 | Rat | Hexachloro-1,3-butadiene | affects expression | EXP | | 6480464 | hexachlorobutadiene affects the expression of LCN2 mRNA | CTD | PMID:21905055 |
Lcn2 | Rat | hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of LCN2 mRNA | CTD | PMID:15159207 |
Lcn2 | Rat | hydroquinone | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of LCN2 mRNA | CTD | PMID:31256213 |
Lcn2 | Rat | hypoxanthine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Hypoxanthine co-treated with potassium oxonate] results in increased expression of LCN2 mRNA and salinomycin inhibits the reaction [[Hypoxanthine co-treated with potassium oxonate] results in increased expression of LCN2 mRNA] | CTD | PMID:39222901 |
Lcn2 | Rat | icariin | multiple interactions | EXP | | 6480464 | icariin inhibits the reaction [Cadmium results in increased expression of LCN2 protein] | CTD | PMID:39197519 |
Lcn2 | Rat | icariin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | icariin inhibits the reaction [Folic Acid results in increased expression of LCN2 mRNA] | CTD | PMID:38272249 |
Lcn2 | Rat | inositol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Inositol inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] | CTD | PMID:37863467 |
Lcn2 | Rat | inositol | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | Inositol inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] | CTD | PMID:37863467 |
Lcn2 | Rat | iohexol | increases expression | EXP | | 6480464 | Iohexol results in increased expression of LCN2 protein | CTD | PMID:36207783 |
Lcn2 | Rat | iohexol | multiple interactions | EXP | | 6480464 | Amlodipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein] more ... | CTD | PMID:36207783 |
Lcn2 | Rat | iomeprol | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein and palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein] | CTD | PMID:26474837 |
Lcn2 | Rat | iron atom | affects metabolic processing | ISO | Lcn2 (Mus musculus) | 6480464 | LCN2 protein affects the metabolism of Iron | CTD | PMID:17194590 |
Lcn2 | Rat | iron atom | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Iron results in increased expression of LCN2 mRNA and Iron results in increased expression of LCN2 protein | CTD | PMID:17350462 |
Lcn2 | Rat | iron(0) | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Iron results in increased expression of LCN2 mRNA and Iron results in increased expression of LCN2 protein | CTD | PMID:17350462 |
Lcn2 | Rat | iron(0) | affects metabolic processing | ISO | Lcn2 (Mus musculus) | 6480464 | LCN2 protein affects the metabolism of Iron | CTD | PMID:17194590 |
Lcn2 | Rat | isocyanuric acid | multiple interactions | EXP | | 6480464 | [cyanuric acid co-treated with melamine] results in increased expression of LCN2 mRNA and [melamine co-treated with cyanuric acid] results in increased expression of LCN2 mRNA | CTD | PMID:21784140 and PMID:23022069 |
Lcn2 | Rat | isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of LCN2 mRNA | CTD | PMID:20623750 |
Lcn2 | Rat | isoprenaline | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased expression of LCN2 mRNA] | CTD | PMID:18089841 |
Lcn2 | Rat | isoprenaline | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of LCN2 mRNA | CTD | PMID:18089841 and PMID:20003209 |
Lcn2 | Rat | isotretinoin | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Isotretinoin results in increased expression of LCN2 mRNA | CTD | PMID:15982314 and PMID:18769122 |
Lcn2 | Rat | ketamine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Ketamine co-treated with Xylazine] results in decreased secretion of LCN2 protein | CTD | PMID:30538007 |
Lcn2 | Rat | ketoconazole | decreases expression | EXP | | 6480464 | Ketoconazole results in decreased expression of LCN2 mRNA | CTD | PMID:18289764 |
Lcn2 | Rat | L-methionine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in increased expression of LCN2 protein] more ... | CTD | PMID:34416350 |
Lcn2 | Rat | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of LCN2 mRNA | CTD | PMID:22641619 |
Lcn2 | Rat | lead diacetate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of LCN2 mRNA] | CTD | PMID:36539177 |
Lcn2 | Rat | lead diacetate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | lead acetate results in increased expression of LCN2 mRNA | CTD | PMID:36539177 |
Lcn2 | Rat | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of LCN2 mRNA | CTD | PMID:36539177 |
Lcn2 | Rat | lead(0) | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Lead results in increased expression of LCN2 mRNA | CTD | PMID:34742682 |
Lcn2 | Rat | lead(0) | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Dietary Fats promotes the reaction [Lead results in increased expression of LCN2 mRNA] and Lead promotes the reaction [Dietary Fats results in increased expression of LCN2 mRNA] | CTD | PMID:34742682 |
Lcn2 | Rat | lipopolysaccharide | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of LCN2 mRNA] more ... | CTD | PMID:16977382 and PMID:18292240 |
Lcn2 | Rat | lipopolysaccharide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of LCN2 mRNA and Lipopolysaccharides results in increased expression of LCN2 protein | CTD | PMID:16977382 more ... |
Lcn2 | Rat | lovastatin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of LCN2 mRNA | CTD | PMID:30853469 |
Lcn2 | Rat | madecassoside | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | madecassoside inhibits the reaction [Cisplatin results in increased expression of LCN2 mRNA] and madecassoside inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] | CTD | PMID:37087747 |
Lcn2 | Rat | maleic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [maleic acid results in increased secretion of LCN2 protein] | CTD | PMID:25119790 |
Lcn2 | Rat | maleic acid | increases secretion | EXP | | 6480464 | maleic acid results in increased secretion of LCN2 protein | CTD | PMID:25119790 |
Lcn2 | Rat | Mecamylamine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of LCN2 mRNA | CTD | PMID:18433785 |
Lcn2 | Rat | medroxyprogesterone acetate | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased expression of LCN2 mRNA | CTD | PMID:15866426 |
Lcn2 | Rat | melamine | multiple interactions | EXP | | 6480464 | [cyanuric acid co-treated with melamine] results in increased expression of LCN2 mRNA and [melamine co-treated with cyanuric acid] results in increased expression of LCN2 mRNA | CTD | PMID:21784140 and PMID:23022069 |
Lcn2 | Rat | melamine | increases expression | EXP | | 6480464 | melamine results in increased expression of LCN2 | CTD | PMID:23052191 |
Lcn2 | Rat | mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of LCN2 mRNA | CTD | PMID:25145654 |
Lcn2 | Rat | mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of LCN2 mRNA | CTD | PMID:16507785 more ... |
Lcn2 | Rat | mercury dichloride | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Mercuric Chloride results in increased expression of LCN2 mRNA | CTD | PMID:27720909 |
Lcn2 | Rat | mercury dichloride | decreases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | Mercuric Chloride results in decreased secretion of LCN2 protein | CTD | PMID:27888128 |
Lcn2 | Rat | mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of LCN2 mRNA | CTD | PMID:25145654 |
Lcn2 | Rat | metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of LCN2 protein] | CTD | PMID:30551545 |
Lcn2 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of LCN2 mRNA | CTD | PMID:22504374 |
Lcn2 | Rat | methotrexate | multiple interactions | EXP | | 6480464 | vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein] | CTD | PMID:29216766 |
Lcn2 | Rat | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of LCN2 protein | CTD | PMID:29216766 |
Lcn2 | Rat | methoxychlor | increases methylation | EXP | | 6480464 | Methoxychlor results in increased methylation of LCN2 gene | CTD | PMID:23303685 |
Lcn2 | Rat | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of LCN2 mRNA | CTD | PMID:28536007 |
Lcn2 | Rat | methylmercury chloride | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of LCN2 mRNA | CTD | PMID:27720909 |
Lcn2 | Rat | microcystin-LR | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of CLDN5 protein more ... | CTD | PMID:34416350 |
Lcn2 | Rat | microcystin-LR | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of LCN2 protein | CTD | PMID:34416350 |
Lcn2 | Rat | morphine | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Morphine results in increased expression of LCN2 mRNA | CTD | PMID:20144693 |
Lcn2 | Rat | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of LCN2 mRNA | CTD | PMID:21515302 |
Lcn2 | Rat | N-methyl-N-nitrosourea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of LCN2 mRNA | CTD | PMID:17412507 |
Lcn2 | Rat | N-nitrosodiethylamine | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of LCN2 mRNA | CTD | PMID:12771043 and PMID:24535843 |
Lcn2 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LCN2 mRNA | CTD | PMID:28943392 |
Lcn2 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LCN2 mRNA | CTD | PMID:24535843 |
Lcn2 | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of LCN2 mRNA | CTD | PMID:17072980 and PMID:25380136 |
Lcn2 | Rat | natamycin | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Natamycin results in increased expression of LCN2 mRNA | CTD | PMID:22863853 |
Lcn2 | Rat | nevirapine | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Nevirapine results in increased expression of LCN2 mRNA | CTD | PMID:38636494 |
Lcn2 | Rat | nickel atom | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Nickel results in increased expression of LCN2 mRNA | CTD | PMID:12540486 |
Lcn2 | Rat | nickel atom | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Nickel results in increased expression of LCN2 mRNA | CTD | PMID:24768652 and PMID:25583101 |
Lcn2 | Rat | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of LCN2 mRNA | CTD | PMID:22546817 |
Lcn2 | Rat | nickel sulfate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | nickel sulfate results in increased expression of LCN2 mRNA | CTD | PMID:16100012 |
Lcn2 | Rat | nifedipine | multiple interactions | EXP | | 6480464 | Nifedipine inhibits the reaction [Iohexol results in increased expression of LCN2 protein] | CTD | PMID:36207783 |
Lcn2 | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of LCN2 mRNA and nitrofen results in increased expression of LCN2 protein | CTD | PMID:23114405 |
Lcn2 | Rat | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of LCN2 mRNA | CTD | PMID:27592368 and PMID:33484710 |
Lcn2 | Rat | Nutlin-3 | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | nutlin 3 inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] | CTD | PMID:32856486 |
Lcn2 | Rat | nystatin | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Nystatin results in increased expression of LCN2 mRNA | CTD | PMID:22863853 |
Lcn2 | Rat | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of LCN2 and ochratoxin A results in increased expression of LCN2 mRNA | CTD | PMID:18308701 and PMID:25218026 |
Lcn2 | Rat | ochratoxin A | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein | CTD | PMID:36227364 |
Lcn2 | Rat | Ondansetron | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Ondansetron promotes the reaction [Cisplatin results in increased expression of LCN2 mRNA] | CTD | PMID:24001450 |
Lcn2 | Rat | oxybenzone | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | oxybenzone results in decreased expression of LCN2 mRNA | CTD | PMID:39343157 |
Lcn2 | Rat | ozone | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LCN2 mRNA more ... | CTD | PMID:19555225 more ... |
Lcn2 | Rat | ozone | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Ozone results in increased expression of LCN2 mRNA | CTD | PMID:23033980 |
Lcn2 | Rat | ozone | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Ozone results in increased expression of LCN2 mRNA and Ozone results in increased expression of LCN2 protein | CTD | PMID:12763052 more ... |
Lcn2 | Rat | palmitoyl ethanolamide | multiple interactions | EXP | | 6480464 | palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein] | CTD | PMID:26474837 |
Lcn2 | Rat | paracetamol | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Acetaminophen results in increased expression of LCN2 protein] more ... | CTD | PMID:22461450 more ... |
Lcn2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of LCN2 mRNA | CTD | PMID:33387578 |
Lcn2 | Rat | paracetamol | decreases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased secretion of LCN2 protein | CTD | PMID:27888128 |
Lcn2 | Rat | paracetamol | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of LCN2 mRNA | CTD | PMID:27888128 |
Lcn2 | Rat | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of LCN2 mRNA | CTD | PMID:20623750 |
Lcn2 | Rat | paracetamol | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of LCN2 mRNA | CTD | PMID:17562736 |
Lcn2 | Rat | paracetamol | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of LCN2 mRNA and Acetaminophen results in increased expression of LCN2 protein | CTD | PMID:20100502 more ... |
Lcn2 | Rat | paraquat | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [ABCB1A gene mutant form results in increased susceptibility to Paraquat] which results in increased expression of LCN2 mRNA more ... | CTD | PMID:25015657 and PMID:33838153 |
Lcn2 | Rat | paraquat | increases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Paraquat results in increased secretion of LCN2 protein | CTD | PMID:33838153 |
Lcn2 | Rat | paraquat | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Paraquat results in increased expression of LCN2 mRNA and Paraquat results in increased expression of LCN2 protein | CTD | PMID:21463325 and PMID:26345256 |
Lcn2 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of LCN2 mRNA | CTD | PMID:37995155 |
Lcn2 | Rat | perfluorononanoic acid | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in decreased expression of LCN2 mRNA | CTD | PMID:33483757 |
Lcn2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in decreased expression of LCN2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LCN2 mRNA | CTD | PMID:33483757 and PMID:36331819 |
Lcn2 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of LCN2 mRNA | CTD | PMID:31926186 |
Lcn2 | Rat | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of LCN2 mRNA | CTD | PMID:28973641 |
Lcn2 | Rat | phenobarbital | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of LCN2 mRNA | CTD | PMID:19270015 |
Lcn2 | Rat | phenobarbital | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of LCN2 mRNA | CTD | PMID:23091169 |
Lcn2 | Rat | phenobarbital | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LCN2 mRNA | CTD | PMID:24535843 |
Lcn2 | Rat | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of LCN2 mRNA | CTD | PMID:15215175 |
Lcn2 | Rat | pinostrobin | multiple interactions | EXP | | 6480464 | pinostrobin inhibits the reaction [Cadmium results in increased expression of LCN2 protein] | CTD | PMID:37342552 |
Lcn2 | Rat | pirinixic acid | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of LCN2 mRNA | CTD | PMID:17321000 |
Lcn2 | Rat | pirinixic acid | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA] more ... | CTD | PMID:17321000 and PMID:27853831 |
Lcn2 | Rat | pirinixic acid | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of LCN2 mRNA | CTD | PMID:18445702 |
Lcn2 | Rat | Potassium 2,6-dihydroxytriazinecarboxylate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Hypoxanthine co-treated with potassium oxonate] results in increased expression of LCN2 mRNA and salinomycin inhibits the reaction [[Hypoxanthine co-treated with potassium oxonate] results in increased expression of LCN2 mRNA] | CTD | PMID:39222901 |
Lcn2 | Rat | potassium bromate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] | CTD | PMID:27082013 |
Lcn2 | Rat | prednisolone | decreases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Prednisolone results in decreased secretion of LCN2 protein | CTD | PMID:28003376 |
Lcn2 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of LCN2 mRNA | CTD | PMID:28903501 |
Lcn2 | Rat | procymidone | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | procymidone results in decreased expression of LCN2 mRNA | CTD | PMID:36764477 |
Lcn2 | Rat | progesterone | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Progesterone affects the expression of LCN2 mRNA | CTD | PMID:17251523 |
Lcn2 | Rat | propanal | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of LCN2 mRNA | CTD | PMID:26079696 |
Lcn2 | Rat | propiconazole | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | propiconazole results in increased expression of LCN2 mRNA | CTD | PMID:21278054 |
Lcn2 | Rat | protein kinase inhibitor | decreases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Protein Kinase Inhibitors results in decreased secretion of LCN2 protein | CTD | PMID:28003376 |
Lcn2 | Rat | pyrrolidine dithiocarbamate | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of LCN2 mRNA] | CTD | PMID:36539177 |
Lcn2 | Rat | quartz | increases expression | EXP | | 6480464 | Quartz results in increased expression of LCN2 mRNA | CTD | PMID:19836432 |
Lcn2 | Rat | rac-lactic acid | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of LCN2 mRNA | CTD | PMID:30851411 |
Lcn2 | Rat | raloxifene | affects expression | ISO | LCN2 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride affects the expression of LCN2 mRNA | CTD | PMID:14699072 |
Lcn2 | Rat | resveratrol | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | resveratrol results in decreased expression of LCN2 protein | CTD | PMID:25505154 |
Lcn2 | Rat | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of LCN2 protein | CTD | PMID:25895148 |
Lcn2 | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of LCN2 mRNA | CTD | PMID:25905778 |
Lcn2 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Streptozocin] results in increased expression of LCN2 mRNA | CTD | PMID:25905778 |
Lcn2 | Rat | Rhynchophylline | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | rhyncophylline inhibits the reaction [Paraquat results in increased secretion of LCN2 protein] | CTD | PMID:33838153 |
Lcn2 | Rat | ritodrine | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Ritodrine results in increased expression of LCN2 mRNA | CTD | PMID:23370008 |
Lcn2 | Rat | rotenone | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | Rotenone inhibits the reaction [Acetaminophen results in increased expression of LCN2 mRNA] and Rotenone inhibits the reaction [Acetaminophen results in increased expression of LCN2 protein] | CTD | PMID:30099449 |
Lcn2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Diclofenac promotes the reaction [Buthionine Sulfoximine results in increased expression of LCN2 mRNA] | CTD | PMID:23939143 |
Lcn2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of LCN2 mRNA more ... | CTD | PMID:29154782 more ... |
Lcn2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | EXP | | 6480464 | Buthionine Sulfoximine results in increased expression of LCN2 mRNA | CTD | PMID:23939143 |
Lcn2 | Rat | Salinomycin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | salinomycin inhibits the reaction [[Hypoxanthine co-treated with potassium oxonate] results in increased expression of LCN2 mRNA] | CTD | PMID:39222901 |
Lcn2 | Rat | senecionine | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | senecionine results in increased expression of LCN2 mRNA | CTD | PMID:31606820 |
Lcn2 | Rat | serpentine asbestos | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Asbestos and Serpentine results in increased expression of LCN2 mRNA | CTD | PMID:16251409 |
Lcn2 | Rat | sevoflurane | increases secretion | ISO | Lcn2 (Mus musculus) | 6480464 | Sevoflurane results in increased secretion of LCN2 protein | CTD | PMID:30538007 |
Lcn2 | Rat | silicon dioxide | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of LCN2 mRNA and Silicon Dioxide results in decreased expression of LCN2 mRNA | CTD | PMID:25895662 and PMID:28425640 |
Lcn2 | Rat | silicon dioxide | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Silicon Dioxide co-treated with Ovalbumin] results in increased expression of LCN2 protein | CTD | PMID:38380914 |
Lcn2 | Rat | silicon dioxide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of LCN2 mRNA and Silicon Dioxide results in increased expression of LCN2 protein | CTD | PMID:23221170 more ... |
Lcn2 | Rat | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of LCN2 mRNA | CTD | PMID:22431001 |
Lcn2 | Rat | sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of LCN2 mRNA | CTD | PMID:21865292 |
Lcn2 | Rat | sodium arsenate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of LCN2 mRNA | CTD | PMID:21795629 |
Lcn2 | Rat | sodium arsenite | increases secretion | EXP | | 6480464 | sodium arsenite results in increased secretion of LCN2 protein | CTD | PMID:32736004 |
Lcn2 | Rat | sodium arsenite | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of LCN2 mRNA | CTD | PMID:33933676 |
Lcn2 | Rat | sodium arsenite | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LCN2 mRNA | CTD | PMID:34032870 |
Lcn2 | Rat | sodium arsenite | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of LCN2 mRNA and sodium arsenite results in increased expression of LCN2 protein | CTD | PMID:24570342 and PMID:38568856 |
Lcn2 | Rat | sodium arsenite | decreases methylation | ISO | LCN2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased methylation of LCN2 gene and sodium arsenite results in decreased methylation of LCN2 promoter | CTD | PMID:24570342 |
Lcn2 | Rat | sodium arsenite | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [sodium arsenite results in increased expression of LCN2 mRNA] more ... | CTD | PMID:24570342 |
Lcn2 | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of LCN2 mRNA | CTD | PMID:25993096 |
Lcn2 | Rat | sodium dodecyl sulfate | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of LCN2 mRNA | CTD | PMID:31734321 |
Lcn2 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of LCN2 mRNA | CTD | PMID:19281266 |
Lcn2 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [Resveratrol co-treated with Streptozocin] results in increased expression of LCN2 mRNA more ... | CTD | PMID:25905778 more ... |
Lcn2 | Rat | streptozocin | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats] results in increased expression of LCN2 mRNA and Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of LCN2 mRNA] | CTD | PMID:33484791 |
Lcn2 | Rat | succimer | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Magnetite Nanoparticles co-treated with Succimer] results in increased expression of LCN2 mRNA more ... | CTD | PMID:21641980 more ... |
Lcn2 | Rat | tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of LCN2 mRNA | CTD | PMID:21865292 |
Lcn2 | Rat | tacrolimus hydrate | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Tacrolimus results in increased expression of LCN2 mRNA | CTD | PMID:29362864 |
Lcn2 | Rat | tacrolimus hydrate | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Tacrolimus results in increased expression of LCN2 mRNA | CTD | PMID:29362864 |
Lcn2 | Rat | tamoxifen | affects expression | ISO | LCN2 (Homo sapiens) | 6480464 | Tamoxifen affects the expression of LCN2 mRNA | CTD | PMID:14699072 |
Lcn2 | Rat | tamoxifen | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of LCN2 mRNA | CTD | PMID:20937368 |
Lcn2 | Rat | tannic acid | multiple interactions | EXP | | 6480464 | Tannic Acid inhibits the reaction [Doxorubicin results in increased expression of LCN2 mRNA] | CTD | PMID:35987278 |
Lcn2 | Rat | tert-butyl hydroperoxide | decreases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased secretion of LCN2 protein | CTD | PMID:27888128 |
Lcn2 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA | CTD | PMID:32741896 |
Lcn2 | Rat | tetrachloromethane | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of LCN2 mRNA and PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] | CTD | PMID:16006527 and PMID:28285099 |
Lcn2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | Anthocyanins inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 protein] and schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] | CTD | PMID:30825423 and PMID:31150632 |
Lcn2 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of LCN2 mRNA and Carbon Tetrachloride results in increased expression of LCN2 protein | CTD | PMID:30723492 more ... |
Lcn2 | Rat | tetrachloromethane | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of LCN2 mRNA | CTD | PMID:27339419 more ... |
Lcn2 | Rat | tetrachloromethane | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of LCN2 mRNA | CTD | PMID:17484886 |
Lcn2 | Rat | tetrathiomolybdate(2-) | decreases expression | ISO | LCN2 (Homo sapiens) | 6480464 | tetrathiomolybdate results in decreased expression of LCN2 mRNA | CTD | PMID:37290678 |
Lcn2 | Rat | thallium | multiple interactions | EXP | | 6480464 | [thallium sulfate results in increased abundance of Thallium] which results in increased expression of LCN2 mRNA | CTD | PMID:39361050 |
Lcn2 | Rat | thallium sulfate | multiple interactions | EXP | | 6480464 | [thallium sulfate results in increased abundance of Thallium] which results in increased expression of LCN2 mRNA | CTD | PMID:39361050 |
Lcn2 | Rat | thapsigargin | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of LCN2 mRNA | CTD | PMID:22800509 |
Lcn2 | Rat | thapsigargin | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | Thapsigargin promotes the reaction [DDIT3 protein binds to LCN2 promoter] and Thapsigargin results in increased expression of and results in increased secretion of LCN2 protein | CTD | PMID:22800509 |
Lcn2 | Rat | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LCN2 mRNA | CTD | PMID:28943392 |
Lcn2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LCN2 mRNA | CTD | PMID:34492290 |
Lcn2 | Rat | titanium dioxide | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of LCN2 mRNA | CTD | PMID:23131501 |
Lcn2 | Rat | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of LCN2 mRNA | CTD | PMID:30012374 |
Lcn2 | Rat | titanium dioxide | affects expression | ISO | Lcn2 (Mus musculus) | 6480464 | titanium dioxide affects the expression of LCN2 mRNA | CTD | PMID:17656681 |
Lcn2 | Rat | titanium dioxide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of LCN2 mRNA and titanium dioxide results in increased expression of LCN2 protein | CTD | PMID:21259345 more ... |
Lcn2 | Rat | trans-anethole | multiple interactions | EXP | | 6480464 | anethole inhibits the reaction [Doxorubicin results in increased expression of LCN2 protein] | CTD | PMID:39029857 |
Lcn2 | Rat | trichloroethene | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of LCN2 mRNA | CTD | PMID:25549359 |
Lcn2 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of LCN2 mRNA | CTD | PMID:33387578 |
Lcn2 | Rat | trichloroethene | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of LCN2 mRNA | CTD | PMID:28973375 |
Lcn2 | Rat | trimethyltin | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | trimethyltin results in increased expression of LCN2 mRNA | CTD | PMID:24002884 |
Lcn2 | Rat | triptonide | increases expression | ISO | Lcn2 (Mus musculus) | 6480464 | triptonide results in increased expression of LCN2 mRNA | CTD | PMID:33045310 |
Lcn2 | Rat | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of LCN2 mRNA | CTD | PMID:21515302 |
Lcn2 | Rat | tungsten | decreases expression | ISO | Lcn2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of LCN2 mRNA | CTD | PMID:30912803 |
Lcn2 | Rat | tunicamycin | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of LCN2 mRNA | CTD | PMID:22800509 and PMID:38498338 |
Lcn2 | Rat | tunicamycin | affects response to substance | ISO | LCN2 (Homo sapiens) | 6480464 | LCN2 mRNA affects the susceptibility to Tunicamycin | CTD | PMID:22800509 |
Lcn2 | Rat | valproic acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LCN2 mRNA | CTD | PMID:29154799 and PMID:32623605 |
Lcn2 | Rat | valproic acid | increases methylation | ISO | LCN2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of LCN2 gene | CTD | PMID:29154799 |
Lcn2 | Rat | valproic acid | multiple interactions | ISO | LCN2 (Homo sapiens) | 6480464 | CEBPA protein affects the reaction [Valproic Acid results in increased expression of LCN2 mRNA] | CTD | PMID:32623605 |
Lcn2 | Rat | vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of LCN2 mRNA | CTD | PMID:18289764 |
Lcn2 | Rat | vanillin | multiple interactions | EXP | | 6480464 | vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] and vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein] | CTD | PMID:29216766 |
Lcn2 | Rat | vildagliptin | multiple interactions | EXP | | 6480464 | Vildagliptin inhibits the reaction [Dietary Fats results in increased expression of LCN2 protein] | CTD | PMID:34081941 |
Lcn2 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of LCN2 mRNA | CTD | PMID:19015723 |
Lcn2 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of LCN2 mRNA | CTD | PMID:23034163 |
Lcn2 | Rat | xylazine | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [Ketamine co-treated with Xylazine] results in decreased secretion of LCN2 protein | CTD | PMID:30538007 |
Lcn2 | Rat | zinc protoporphyrin | multiple interactions | EXP | | 6480464 | zinc protoporphyrin inhibits the reaction [Cadmium results in increased expression of LCN2 protein] | CTD | PMID:39025289 |
Lcn2 | Rat | zoledronic acid | increases expression | ISO | LCN2 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of LCN2 mRNA | CTD | PMID:24714768 |
Lcn2 | Rat | zoledronic acid | increases secretion | ISO | LCN2 (Homo sapiens) | 6480464 | zoledronic acid results in increased secretion of LCN2 protein | CTD | PMID:24714768 |
Lcn2 | Rat | zomepirac | multiple interactions | ISO | Lcn2 (Mus musculus) | 6480464 | [zomepirac co-treated with Buthionine Sulfoximine co-treated with tri-o-cresyl phosphate] results in increased expression of LCN2 mRNA and LY6G protein affects the reaction [[zomepirac co-treated with Buthionine Sulfoximine co-treated with tri-o-cresyl phosphate] results in increased expression of LCN2 mRNA] | CTD | PMID:29154782 |